Pharmaceuticals
Pharmaceuticals
Pharmaceutical Solutions
In the rapidly developing pharmaceutical industry, high-purity and high-stability pharmaceutical intermediates are the key to ensuring drug quality and production efficiency. We are committed to providing pharmaceutical companies with one-stop intermediate solutions, covering a variety of key intermediates required for API synthesis, patented drug development, and generic drug production, which are widely used in antibiotics, anti-tumor drugs, cardiovascular drugs, nervous system drugs, and other fields.
Application Fields
- API (raw material) synthesis
- New drug development & preclinical research
- Generic drug preparation
- CRO/CDMO project cooperation
Product List
| Product Name | CAS |
| Pyridine-3-Boronic Acid | 1692-25-7 |
| 4-(2-Aminoethyl)aniline | 13472-00-9 |
| Piperazine-2,5-dione | 106-57-0 |
| 2-Methyl-1-pyrroline | 872-32-2 |
| Neopentyl Alcohol | 75-84-3 |
| 3-Bromofuran-2-carbaldehyde | 14757-78-9 |
| 1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazine | 71257-38-0 |
| Adamantane-1,3,5-triol | 99181-50-7 |
| Ethyl 3-(4-methoxyphenyl)-3-oxopropanoate | 2881-83-6 |
| 6-(4-Hydroxyphenoxy)hexyl acrylate | 161841-12-9 |
| 7-Amino-4-hydroxynaphthalene-2-sulfonic acid | 87-02-5 |
| Benzyl 3-oxocyclobutanecarboxylate | 198995-91-4 |
| 5-Chlorothieno[3,2-b]pyridine | 65977-55-1 |
| 1,5-Diphenylpenta-1,4-dien-3-one | 538-58-9 |
| 1-Acetylindolin-3-one | 16800-68-3 |
| Dibenzothiophene-1-boronic acid | 1245943-60-5 |
| 2-(1H-Pyrrol-1-yl)ethanamine | 29709-35-1 |
| (E)-1,1,1-Trichloro-4-ethoxybut-3-en-2-one | 59938-07-7 |
| 1H-Imidazole-5-acetonitrile | 18502-05-1 |
| 4-Methoxycyclohexanon | 13482-23-0 |
| Benzoic acid, 4-cyclohexyl- | 20029-52-1 |
| 4-Methyl-1-phenylpentan-1-one | 2050-07-9 |
| 4-Hydroxy-7-(phenylamino)naphthalene-2-sulfonic acid | 119-40-4 |
| Neononanoic acid,ethenyl ester | 54423-67-5 |
| 2,4-Dichloro-6,8-difluoroquinazoline | 1598138-90-9 |
| 2-Butyl-1H-imidazole-5-carboxaldehyde | 68282-49-5 |
| 1-(1-Methylethyl)cyclohexyl 2-methyl-2-propenoate | 811440-77-4 |
| 2-((Carboxymethyl)amino)benzoic acid | 612-42-0 |
| Ethyl 1-oxo-2,3-dihydro-1H-indene-5-carboxylate | 150969-57-6 |
| 2-Boc-3,4-dihydro-1H-pyrrolo-[1,2-a]pyrazine-6-carboxylic acid | 1363380-86-2 |
| 5-Brombenzofuran | 23145-07-5 |
| 3-Bromo-1-benzofuran | 59214-70-9 |
| (R)-(-)-2-Amino-1-propanol | 35320-23-1 |
| Ethyl (R)-2-hydroxy-4- phenylbutyrate |
90315-82-5 |
| (2R’3R)-(-)-2’3-Butanediol | 24347-58-8 |
| Ethyl S-4-chloro-3- hydroxybutyrate |
86728-85-0 |
| (s)-(+)-2-Butanol | 4221-99-2 |
| 6-Bromo-1-hexanol | 4286-55-9 |
| 2.5-Dihydroxybenzaldehyde | 1194-98-5 |
| 5′-fluoro-2′-lodoacetophenone | 914225-70-0 |
| 3-Thiopheneacetic acid | 6964-21-2 |
| 2-Bromo-5-fluoroaniline | 1003-99-2 |
| 3’4’5-Trimethoxyaniline | 24313-88-0 |
| 3-Methylpyrazole | 1453-58-3 |
| 2-Benzothiazolamine | 136-95-8 |
| 10-Methoxy-10-oxodecanoic acid | 818-88-2 |
| ofloxacin q-acid | 82419-35-0 |
| Levofloxacin ethylester | 106939-34-8 |
| Levofloxacin q-acid | 100986-89-8 |
| Gatifloxacin q-acid | 112811-72-0 |
| Domperidone maleate | 68077-26-9 |
| ciprofloxacin q-acid | 86393-33-1 |
| Cyclopentanecarbaldehyde | 872-53-7 |
| Cyclopentanemethanol | 3637-61-4 |
| cyclopropylacetic acid | 5239-82-7 |
| cyclopropanemethanol | 2516-33-8 |
| cyclopropanecarboxaldehyde | 1489-69-6 |
| pivaldehyde | 630-19-3 |
| 3-cyclohexene-1-carboxaldehyde | 100-50-5 |
| 3-cyclohexene-1-methanol | 1679-51-2 |
| 3-cyclohexenecarboxylic acid | 4771-80-6 |
| 3-cyclohexene-1-carboxylic acid methyl ester | 6493-77-2 |
| 3-cyclopentyl-acrylonitrile | 591769-05-0 |
| Bis((7-oxabicyclo[4.1.0]heptan-3-yl)methyl) adipate |
3130-19-6 |
| poly(methyl vinyl ether/maleic anhydride) copolymer |
9011-16-9 |
| Methyl vinyl Ether/Maleic Acid CopolyMer | 25153-40-6 |
| poly(Methylvinylether/Maleic Acid) Mixed salts copolymer |
62386-95-2 |
| poly(methyl vinyl ether-alt-maleic acid monoeth-yl ester) | 25087-06-3 25119-68-0 |
| poly(Methyl vinyl Ether-Alt-Maleic Anhydride)’ cross-Linked with 1’9-Decadiene |
136392-67-1 |
| Isosorbide divinyl ether | 40268-97-1 |
| tert-Butyl vinyl ether | 926-02-3 |
| 1’2-Epoxy-4-vinylcyclohexane | 106-86-5 |
| pentaerythritol Triallyl Ether | 1471-17-6 |
| Acrolein dimethyl acetal | 6044-68-4 |
| poly(isobutyl vinyl ether) | 9003-44-5 |
| 3,9-Divinyl-2,4,8,10- tetraoxaspiro[5.5]undecane |
78-19-3 |
| 5-METHYL-3-HEXEN-2-ONE | 5166-53-0 |
| Levofloxacin lactate | 294662-18-3 |
| Levofloxacin hcl | 177325-13-2 |
| Simvastatin | 79902-63-9 |
| Levofloxacin | 100986-85-4 |
| Norfloxacin | 70458-96-7 |
| Norfloxacin nicotinate | 1 18803-81-9 |
| Gatifloxacin | 112811-59-3 |
| Gatifloxacin hcl | 160738-57-8 |
| Enrofloxacin hydrochloride | 1 12732-17-9 |
| Semaglutide | 9 10463-68-2 |
| Tirzepatide | 2023788-19-2 |
| Nicotinamide ribosidechloride | 23111-00-4 |
| Reduced NicotinamideAdenineDinucieotide | 606-68-8 |
| β-NicotinamideMononucleotide | 1094-61-7 |
| Reduced B-nicotinamide-mononucleotid | 108347-85-9 |
Pharmaceuticals
NO.
Product Name
Basic Character
Application
Reference Dosage
QUICK SEARCH
Contact Us
Contact Skychem Group for more chemical solutions, If you have questions or need more information, please contact us.
Technical Service
Whatsapp & Telephone:
+86-15267084488
E-mail:
Info@skychemi.com
Fax:
+86-571-86750661
Address:
5th Floor, Southeast Technology r&d Center,Xiaoshan District, Hangzhou, China
